Enhanced antitumor effect of cisplatin in human NSCLC cells by tumor suppressor LKB1

Cancer Gene Therapy,

This study suggests that the combination of LKB1 gene therapy with low–dose cisplatin–based chemotherapy may be a potent therapeutic strategy for lung cancer.

Print Article Summary Cat 2 CME Report